In a preterm infant born at ≤1500 g or ≤32 weeks gestation (or 1500‑2000 g/32‑34 weeks with an unstable clinical course), when should the initial retinal examination for retinopathy of prematurity be performed, and how should follow‑up examinations be scheduled based on the initial findings?

ROP Screening

All preterm infants born at ≤1500 g or ≤32 weeks gestation should have their initial retinal examination at 31 weeks postmenstrual age (PMA) or 4 weeks postnatal age (PNA), whichever comes later, with follow-up intervals determined by the severity of findings ranging from 1-2 weeks for high-risk disease to discharge if no ROP is detected and full vascularization is confirmed.

Initial Screening Timing

The timing of the first examination must balance two critical factors: avoiding unnecessary early examinations while ensuring severe ROP is never missed. Based on the most recent evidence, the initial screening should occur at 31 weeks PMA or 4 weeks PNA, whichever comes later 1, 2. This represents an evolution from older criteria that used 32 weeks as the cutoff.

Key Evidence Supporting This Timing:

• A 2021 study of 550 extremely preterm infants (<27 weeks gestation) found that no infant required laser therapy prior to 32 weeks PMA, and none had severe ROP before 31 weeks PMA 1
• The 2022 UK guidelines lowered the gestational age screening criterion to below 31 weeks, representing the most current international standard 2
• Research shows ROP is typically first detected around 34 weeks PMA and 7.2 weeks PNA, regardless of birth weight 3

Birth Weight and Gestational Age Criteria:

Screen all infants meeting ANY of these criteria:

• Birth weight ≤1500 g
• Gestational age ≤32 weeks (or ≤31 weeks per most recent UK guidelines)
• Birth weight 1500-2000 g OR gestational age 32-34 weeks with unstable clinical course (oxygen therapy, sepsis, apnea, mechanical ventilation, poor weight gain) 4, 5

Critical caveat: Infants with multiple systemic risk factors—particularly poor postnatal weight gain, prolonged oxygen therapy, sepsis, or extended mechanical ventilation—may develop treatment-requiring ROP even if they fall slightly outside standard criteria 5. Clinical judgment must be exercised for borderline cases with significant risk factors.

Follow-Up Examination Schedule

The frequency of follow-up examinations is risk-stratified based on initial findings:

No ROP Detected:

• Repeat examination every 2 weeks until full retinal vascularization is confirmed
• Can discontinue screening once vascularization reaches zone III (peripheral retina) without any ROP

Stage 1 or Stage 2 ROP (Mild to Moderate):

• Examine every 1-2 weeks depending on zone and extent
• Zone I disease requires more frequent monitoring (weekly)
• Zone II disease can be monitored every 1-2 weeks

Stage 3 ROP or "Plus Disease":

• Examine every 1 week or more frequently
• These infants are at high risk for rapid progression to treatment-requiring disease
• Plus disease (vascular dilation and tortuosity) is a major red flag requiring urgent ophthalmology involvement 6

Treatment-Requiring ROP:

• Threshold disease or Type 1 pre-threshold disease requires immediate treatment (within 48-72 hours)
• Treatment options include laser photocoagulation (first-line) or anti-VEGF injections 7
• After treatment, continue examinations until complete vascularization, as unfavorable outcomes occur in 9-14% despite treatment 6

Critical Timing Considerations by Birth Weight

The earliest PMA and PNA when threshold ROP develops varies by birth weight 8:

• ≤1000 g (ELBW): Earliest threshold at 33 weeks PMA and 7 weeks PNA
• 1001-1250 g: Earliest threshold at 34 weeks PMA and 6 weeks PNA
• >1250 g: Earliest threshold at 35 weeks PMA and 4 weeks PNA

This data supports the dual criteria approach (31 weeks PMA OR 4 weeks PNA, whichever is later) as it captures all infants before they could develop treatment-requiring disease.

Common Pitfalls to Avoid

1. Never interrupt screening due to discharge: Approximately 28-32% of infants who develop threshold ROP are detected after NICU discharge 8. Ensure robust outpatient follow-up is arranged before discharge.

2. Don't rely solely on gestational age/birth weight: Infants with significant risk factors (oxygen exposure, sepsis, apnea, poor weight gain) may develop severe ROP even if slightly outside standard criteria 4, 5.

3. Don't delay treatment: Once treatment criteria are met, intervention should occur within 48-72 hours to prevent retinal detachment and blindness 6.

4. Continue examinations until full vascularization: Even after ROP regresses spontaneously or with treatment, continue monitoring until retinal vessels reach the ora serrata (zone III) to detect late complications 6.

The screening algorithm prioritizes preventing blindness while minimizing unnecessary examinations in this vulnerable population. When in doubt, err on the side of more frequent examinations rather than risk missing rapidly progressive disease.